Epstein-Barr virus (EBV) is a prevalent, worldwide infection of which the most common clinical manifestation is infectious mononucleosis. An accurate diagnosis of infectious mononucleosis, which should be distinguished from "glandular fever", depends on finding appropriate, clinical, haematological and serological evidence of the disease. ' Rapid ELISA for detection of EBV Discussion The rapid ELISA test described is marketed as a test for infectious mononucleosis, but it is more correctly a test for Epstein-Barr virus (EBV) infection. The test is based on peptide 62, an Epstein-Barr nuclear antigen (EBNA-1), coated on to the solid phase. The initial good performance of the test4 and the subsequent adaptation to a rapid test5 (six minutes) was impressive, and it is understandable that the test has been adopted by many laboratories, but our results show that this test, in its present form, has serious limitations. The visual assessment of the colour change contributes to the speed of the test. Unfortunately, there are great observer differences in determining the intensity of colour. The decision may be further complicated when many samples are being tested as each paddle has to be assessed separately, and the manufacturers state that comparisons between paddles should not be made. Although the paddle system is clever and useful, if a few samples are being tested the system becomes cumbersome when there are many samples.
It has been suggested that the rapid ELISA is more sensitive than the PBD as it can detect EBV infection which is heterophile antibody negative.5 We found that the rapid ELISA detected less than half of such samples, and with the PBD positive samples there was a failure to detect 44% by one observer and 28% by another. Thus in our hands the positive predictive value of the test when compared with IgM EBV VCA was 63%. Ironically, the very samples for which the manufacturers claim an advantage for the rapid ELISA, IgM VCA positive, PBD negative, are the ones which the rapid ELISA has most difficulty identifying. When compared with the IgM EBV VCA, which is generally accepted to be the best test for diagnosing EBV infection,2 the rapid ELISA did not do well.
The rapid ELISA also lacked specificity.
Previous assessments45 had not tested many serum samples that were positive for other infections. The rapid ELISA produced many false positive results ( 
